Testosterone Treatment in Multiple Sclerosis Patients
Author Information
Author(s): Stefan M Gold, Sara Chalifoux, Barbara S Giesser, Rhonda R Voskuhl
Primary Institution: University of California Los Angeles
Hypothesis
Can testosterone treatment modulate immune responses and increase neurotrophic factor production in multiple sclerosis patients?
Conclusion
Testosterone treatment in MS patients shows immunomodulatory effects and increases neurotrophic factor production.
Supporting Evidence
- Testosterone treatment significantly reduced DTH recall responses.
- There was a significant decrease in IL-2 production during treatment.
- Increased production of BDNF and PDGF-BB was observed during treatment.
Takeaway
This study found that giving testosterone to men with multiple sclerosis helped their immune system and increased important brain growth factors.
Methodology
Ten male MS patients were treated with testosterone gel for 12 months after a 6-month observation period, with blood samples taken to analyze immune responses.
Potential Biases
Potential bias due to the open-label design of the study.
Limitations
Small sample size and lack of a control group.
Participant Demographics
Ten male patients with relapsing-remitting multiple sclerosis, mean age 46 (range 29–61).
Statistical Information
P-Value
p = .03
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website